{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:38:48Z","timestamp":1779370728496,"version":"3.53.0"},"reference-count":58,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Early diagnosis and monitoring of liver fibrosis in chronic hepatitis B are crucial for effective disease management and prognosis. Traditionally, percutaneous liver biopsy has been regarded as the gold standard for assessing the degree of fibrosis histopathologically. However, this method has several drawbacks. Consequently, non-invasive serum scoring systems are becoming increasingly preferred. These serum scoring systems have emerged as valuable non-invasive tools for predicting liver fibrosis in patients with chronic hepatitis B. Multiple serum-based scoring systems have been developed and validated for this purpose. The aim of this study is to determine the role of serum scoring systems in chronic hepatitis B, evaluate their performance, and analyze their correlation with liver biopsy results. Materials and Methods: Patients diagnosed with Chronic Hepatitis B who underwent liver biopsy and were found to have liver fibrosis associated with chronic hepatitis B between August 2018 and July 2024 were included in this retrospective comparative case-control study and liver function tests, INR, alpha-fetoprotein levels, hemogram parameters, kidney function tests, and cholesterol levels at the time of biopsy were recorded. Results: The present study included a total of 249 patients, comprising 138 men (55.5%; mean age 42.1 years) and 111 women (44.5%; mean age 45.8 \u00b1 13.5 years). The results of sixteen commonly used scoring systems in the current literature were evaluated for predicting fibrosis. According to ROC analysis, the most notable score identified was the KING score (0.775). The subsequent scores, in order, were AGAP (0.768), GUCI (0.748), FIB-4 (0.735), APRI (0.729), and S-INDEX (0.701). Conclusions: Non-invasive methods offer potential advantages over liver biopsy. While these scoring systems demonstrate good accuracy in identifying advanced fibrosis and cirrhosis, their performance in detecting mild to moderate fibrosis is generally less reliable. They can function as preliminary screening tests to identify patients who may require further evaluation or to prioritize individuals for more advanced imaging studies or liver biopsy.<\/jats:p>","DOI":"10.3390\/medicina61081490","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:18:14Z","timestamp":1755695894000},"page":"1490","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Use of Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B: A Retrospective Case-Control Study"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-7931","authenticated-orcid":false,"given":"M\u00fcge","family":"\u00d6zg\u00fcler","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Elaz\u0131\u011f Fethi Sekin City Training, and Research Hospital, University of Health Sciences, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5278-6875","authenticated-orcid":false,"given":"Samet","family":"Durak","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Elaz\u0131\u011f Fethi Sekin City Training, and Research Hospital, University of Health Sciences, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-199X","authenticated-orcid":false,"given":"\u00d6zgen Arslan","family":"Solmaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Elaz\u0131\u011f Fethi Sekin City Training, and Research Hospital, University of Health Science, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-1702","authenticated-orcid":false,"given":"G\u00fclden","family":"Eser Karl\u0131da\u011f","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Elaz\u0131\u011f Fethi Sekin City Training, and Research Hospital, University of Health Sciences, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6448-3318","authenticated-orcid":false,"given":"\u00d6m\u00fcr","family":"G\u00fcnda\u011f","sequence":"additional","affiliation":[{"name":"Clinic of Infect\u0131ous Diseases and Clinical Microbiology, Elaz\u0131\u011f Fethi Sekin City Hospital, Ministry of Health, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-0180","authenticated-orcid":false,"given":"Yasemin","family":"K\u0131r\u0131k","sequence":"additional","affiliation":[{"name":"Clinic of Infect\u0131ous Diseases and Clinical Microbiology, Elaz\u0131\u011f Fethi Sekin City Hospital, Ministry of Health, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9892","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"Tan\u0131r","sequence":"additional","affiliation":[{"name":"Clinic of Infect\u0131ous Diseases and Clinical Microbiology, Elaz\u0131\u011f Fethi Sekin City Hospital, Ministry of Health, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0863-8530","authenticated-orcid":false,"given":"S\u00fcmeyye","family":"Selim Kara","sequence":"additional","affiliation":[{"name":"Clinic of Infect\u0131ous Diseases and Clinical Microbiology, Elaz\u0131\u011f Fethi Sekin City Hospital, Ministry of Health, 23280 Elaz\u0131g, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, March 27). Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries, Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4274\/vhd.09326","article-title":"King\u2019s Score may be More Effective in the Determination of Severe Fibrosis in Chronic Hepatitis B Infections","volume":"23","author":"Karacaer","year":"2017","journal-title":"Viral Hepat. Derg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"22944","DOI":"10.18632\/oncotarget.14430","article-title":"Diagnostic value of FIB-4 for liver fibrosis in patients with hepatitis B: A meta-analysis of diagnostic test","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_8","first-page":"e57162","article-title":"Navigating Cirrhosis: A Comprehensive Review of Liver Scoring Systems for Diagnosis and Prognosis","volume":"16","author":"Kotak","year":"2024","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"29544","DOI":"10.1038\/s41598-024-79826-w","article-title":"Comparison of different noninvasive scores for assessing hepatic fibrosis in a cohort of chronic hepatitis C patients","volume":"14","author":"Elakel","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_10","first-page":"1302","article-title":"Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection","volume":"92","author":"Bonacini","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100544","DOI":"10.1016\/j.aohep.2021.100544","article-title":"A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B","volume":"27","author":"Okdemir","year":"2022","journal-title":"Ann. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.51821\/85.1.9156","article-title":"GPR, King\u2019s Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients","volume":"85","author":"Ekin","year":"2022","journal-title":"Acta Gastro Enterol. Belg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12876-024-03270-3","article-title":"Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/labmed\/lmv015","article-title":"Selected Noninvasive Markers in Diagnosing Liver Diseases","volume":"47","author":"Gudowska","year":"2016","journal-title":"Lab. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.dld.2019.01.011","article-title":"Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis","volume":"51","author":"Wang","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-230X-11-44","article-title":"A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)","volume":"11","author":"Ahmad","year":"2011","journal-title":"BMC Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5114\/ceh.2016.63872","article-title":"Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases","volume":"4","author":"Gudowska","year":"2016","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3406789","DOI":"10.1155\/2018\/3406789","article-title":"Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis","volume":"2018","author":"Qi","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e100182","DOI":"10.1371\/journal.pone.0100182","article-title":"The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: A systematic review and meta-analysis of diagnostic test accuracy","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bera, C., Hamdan-Perez, N., and Patel, K. (2024). Non-Invasive Assessment of Liver Fibrosis in Hepatitisn B Patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13041046"},{"key":"ref_21","first-page":"998","article-title":"Performance of FIB4 and APRI scores for the prediction of fibrosis in patients with chronic hepatitis B virus infection","volume":"98","author":"Medhioub","year":"2020","journal-title":"Tunis. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jvh.12279","article-title":"APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: The Chronic Hepatitis Cohort Study (CHeCS)","volume":"21","author":"Teshale","year":"2014","journal-title":"J. Viral Hepat."},{"key":"ref_23","first-page":"e19342","article-title":"A Comparative Analysis of the APRI, FIB4, and FibroScan Score in Evaluating the Severity of Chronic Liver Disease in Chronic Hepatitis B Patients in India","volume":"13","author":"Rungta","year":"2021","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/s41598-017-03589-w","article-title":"New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1440-1746.2010.06383.x","article-title":"Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B","volume":"25","author":"Zhou","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e4679","DOI":"10.1097\/MD.0000000000004679","article-title":"A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation","volume":"95","author":"Nishikawa","year":"2016","journal-title":"Medicine"},{"key":"ref_27","first-page":"740","article-title":"The diagnostic value of a globulin\/platelet model for evaluating liver fibrosis in chronic hepatitis B patients","volume":"107","author":"Coskun","year":"2015","journal-title":"Rev. Esp. de Enfermedades Dig."},{"key":"ref_28","first-page":"137","article-title":"The value of APGA score, fibrosis index for diagnosing liver fibrosis in patients with chronic hepatitis B","volume":"175","author":"Vu","year":"2024","journal-title":"La Clin. Ter."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1158\/1078-0432.CCR-12-3363","article-title":"Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma","volume":"19","author":"Zhu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1535370220914252","article-title":"Prognostic value of non-invasive fibrosis indices post-curative resection in hepatitis-B-associated hepatocellular carcinoma patients","volume":"245","author":"Zhang","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.transproceed.2018.03.005","article-title":"Diagnostic usefulness of APRI and FIB-4 for the prediction of liver fibrosis after liver transplantation in patients infected with hepatitis C virus","volume":"50","author":"Imai","year":"2018","journal-title":"Transplant. Proc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1452841","DOI":"10.3389\/fmolb.2024.1452841","article-title":"Development and validation of a nomogram for predicting advanced liver fibrosis in patients with chronic hepatitis B","volume":"11","author":"Han","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"ref_33","first-page":"25","article-title":"Evaluation of fibrosis with noninvasive biochemical tests in chronic viral hepatitis B","volume":"4","author":"Kaya","year":"2023","journal-title":"Hepatol. Forum"},{"key":"ref_34","first-page":"18","article-title":"Evaluation of Liver Fibrosis by Ten Noninvasive Methods in Evaluation of Liver Fibrosis by Ten Noninvasive Methods in Patients with Chronic Hepatitis B: A Comparative Study","volume":"4","year":"2018","journal-title":"Akdeniz Med. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/MEG.0000000000000468","article-title":"AST\/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients","volume":"27","author":"Eminler","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/jvh.13806","article-title":"Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta","volume":"30","author":"Kalkan","year":"2023","journal-title":"J. Viral Hepat."},{"key":"ref_37","first-page":"533","article-title":"Comparison of Invasive and Non-Invasive Liver Fibrosis Indicators in Chronic Hepatitis B Patients","volume":"21","author":"Ceylan","year":"2024","journal-title":"J. Harran Univ. Med. Fac."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6635625","DOI":"10.1155\/2024\/6635625","article-title":"Macrophage-2-Binding Protein Glycosylation Isomer (M2BPGi) and AGAP Score as Markers of Noninvasive Test for Liver Fibrosis versus FibroScan in Chronic Hepatitis B Patients: A Retrospective Observational Study","volume":"2024","author":"Pramono","year":"2024","journal-title":"Int. J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/MEG.0000000000001428","article-title":"Diagnostic accuracy of different noninvasive scores for detecting advanced fibrosis in chronic hepatitis B","volume":"31","author":"Hamidi","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"727706","DOI":"10.3389\/fmed.2021.727706","article-title":"A Novel Non-invasive Model Based on GPR for the Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B","volume":"8","author":"Ding","year":"2021","journal-title":"Front. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: A need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.51821\/87.3.13290","article-title":"Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients","volume":"87","author":"Dilcan","year":"2024","journal-title":"Acta Gastro Enterol. Belg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365513.2013.773592","article-title":"The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients","volume":"73","author":"Erdogan","year":"2013","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jvh.13031","article-title":"China HepB-Related Fibrosis Assessment Research Group Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients","volume":"26","author":"Dong","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_45","first-page":"e199","article-title":"Non-invasive fibrosis tests are correlated with necroinflammatory activity of liver in patients with chronic hepatitis B","volume":"165","author":"Ozyalvacli","year":"2014","journal-title":"Clin. Ter."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.3748\/wjg.v26.i27.3952","article-title":"Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients","volume":"26","author":"Kang","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e9781","DOI":"10.1097\/MD.0000000000009781","article-title":"Assessment of liver fibrosis in Egyptian chronic hepatitis B patients: A comparative study including 5 noninvasive indexes","volume":"97","author":"Omar","year":"2018","journal-title":"Medicine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.2147\/IJGM.S364216","article-title":"Retrospective evaluation of non-invasive assessment based on routine laboratory markers for assessing advanced liver fibrosis in chronic hepatitis B patients","volume":"15","author":"Wang","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_49","first-page":"731","article-title":"Pentraxin-3: A novel marker for indicating liver fibrosis in chronic hepatitis B patients","volume":"32","author":"Tatar","year":"2021","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/etm.2020.8798","article-title":"Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B","volume":"20","author":"Tsuji","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.21037\/apm-21-957","article-title":"A noninvasive diagnostic model for significant liver fibrosis in patients with chronic hepatitis B based on CHI3L1 and routine clinical indicators","volume":"10","author":"Huang","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2018.04.036","article-title":"The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus","volume":"483","author":"Dong","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1470320311434241","article-title":"Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B","volume":"13","author":"Purnak","year":"2012","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijid.2016.06.004","article-title":"Serum platelet-derived growth factor BB levels: A potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B","volume":"49","author":"Zhou","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuint.2012.06.016","article-title":"Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene","volume":"61","author":"Johnson","year":"2012","journal-title":"Neurochem. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/anae.14545","article-title":"Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: A systematic review","volume":"74","author":"Andersson","year":"2019","journal-title":"Anaesthesia"},{"key":"ref_57","first-page":"726","article-title":"Butyrylcholinesterase as a biochemical marker","volume":"114","author":"Pohanka","year":"2013","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 67, 370\u2013398.","DOI":"10.1016\/j.jhep.2017.03.021"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1490\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:31:36Z","timestamp":1760034696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081490"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081490","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}